Dong-A ST Co., Ltd. (170900.KS)
170900.KS Stock Price Chart
Explore Dong-A ST Co., Ltd. interactive price chart. Choose custom timeframes to analyze 170900.KS price movements and trends.
170900.KS Company Profile
Discover essential business fundamentals and corporate details for Dong-A ST Co., Ltd. (170900.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
5 Apr 2013
Employees
1.69K
Website
https://www.donga-st.comCEO
Jae-Hong Park
Description
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin for infertility and annovulation; Growtropin II for growth failure due to an inadequate secretion of growth hormone and idiopathic short stature; Mainta for non-small cell lung cancer and malignant pleural mesothelioma; Monotaxel for breast, non-small cell lung, prostate, head, and neck cancers, as well as gastric adenocarcinoma; Motilitone for use in functional dyspepsia treatment; Stillen for the treatment of gastritis; Suganon for diabetes treatment; Terizidone for active pulmonary and extra-pulmonary tuberculosis; and Zydena for erectile dysfunction treatment. The company also provides licensed-in and licensed-out drugs; and medical devices, which cover high technology medical devices, custom made products, and sets of artificial cardiac circuits for use in open-heart surgery. Dong-A ST Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
170900.KS Financial Timeline
Browse a chronological timeline of Dong-A ST Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 30 Oct 2025
Earnings released on 24 Jul 2025
EPS came in at -₩1.48K , while revenue for the quarter reached ₩193.99B , beating expectations by +3.68%.
Earnings released on 30 Apr 2025
EPS came in at -₩1.35K falling short of the estimated ₩1.07K by -225.94%, while revenue for the quarter reached ₩182.09B , beating expectations by +17.70%.
Dividend declared on 13 Mar 2025
A dividend of ₩700.00 per share was announced, adjusted to ₩700.00. The dividend was paid on 18 Apr 2025.
Stock split effective on 13 Mar 2025
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Feb 2025
EPS came in at ₩1.76K , while revenue for the quarter reached ₩178.62B , beating expectations by +4.34%.
Earnings released on 1 Nov 2024
EPS came in at -₩3.11K falling short of the estimated ₩1.31K by -336.96%, while revenue for the quarter reached ₩191.50B , beating expectations by +9.07%.
Earnings released on 25 Jul 2024
EPS came in at ₩839.00 falling short of the estimated ₩840.58 by -0.19%, while revenue for the quarter reached ₩172.38B , beating expectations by +9.32%.
Earnings released on 2 May 2024
EPS came in at -₩995.53 falling short of the estimated ₩676.31 by -247.20%, while revenue for the quarter reached ₩155.36B , beating expectations by +2.03%.
Earnings released on 26 Mar 2024
EPS came in at -₩800.00 falling short of the estimated ₩803.92 by -199.51%, while revenue for the quarter reached ₩181.06B , beating expectations by +10.27%.
Dividend declared on 27 Dec 2023
A dividend of ₩700.00 per share was announced, adjusted to ₩686.27. The dividend was paid on 19 Apr 2024.
Stock split effective on 27 Dec 2023
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Oct 2023
EPS came in at ₩539.22 falling short of the estimated ₩916.69 by -41.18%, while revenue for the quarter reached ₩166.60B , beating expectations by +2.57%.
Earnings released on 14 Aug 2023
EPS came in at ₩215.14 falling short of the estimated ₩817.97 by -73.70%, while revenue for the quarter reached ₩169.21B , beating expectations by +5.48%.
Earnings released on 27 Apr 2023
EPS came in at ₩675.00 falling short of the estimated ₩685.85 by -1.58%, while revenue for the quarter reached ₩147.11B , beating expectations by +4.17%.
Earnings released on 13 Feb 2023
EPS came in at -₩1.54K falling short of the estimated ₩551.97 by -379.12%, while revenue for the quarter reached ₩154.16B , missing expectations by -4.95%.
Dividend declared on 28 Dec 2022
A dividend of ₩700.00 per share was announced, adjusted to ₩672.82. The dividend was paid on 21 Apr 2023.
Stock split effective on 28 Dec 2022
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Oct 2022
EPS came in at ₩2.50K surpassing the estimated ₩1.22K by +105.09%, while revenue for the quarter reached ₩161.67B , missing expectations by -1.41%.
Earnings released on 27 Jul 2022
EPS came in at ₩350.98 falling short of the estimated ₩860.81 by -59.23%, while revenue for the quarter reached ₩163.30B , beating expectations by +2.03%.
Earnings released on 27 Apr 2022
EPS came in at ₩201.96 falling short of the estimated ₩624.49 by -67.66%, while revenue for the quarter reached ₩156.26B , beating expectations by +1.80%.
Earnings released on 8 Feb 2022
EPS came in at -₩630.39 falling short of the estimated ₩406.58 by -255.05%, while revenue for the quarter reached ₩152.92B , missing expectations by -1.57%.
Dividend declared on 29 Dec 2021
A dividend of ₩1.00K per share was announced, adjusted to ₩942.32. The dividend was paid on 18 Apr 2022.
Earnings released on 2 Nov 2021
EPS came in at ₩1.25K surpassing the estimated ₩975.97 by +28.38%, while revenue for the quarter reached ₩151.86B .
Earnings released on 10 Aug 2021
EPS came in at ₩728.43 falling short of the estimated ₩1.12K by -34.77%, while revenue for the quarter reached ₩147.52B .
Earnings released on 28 Apr 2021
EPS came in at ₩88.24 falling short of the estimated ₩1.17K by -92.44%, while revenue for the quarter reached ₩140.92B .
Earnings released on 23 Feb 2021
EPS came in at -₩1.72K falling short of the estimated ₩265.43 by -749.28%, while revenue for the quarter reached ₩128.20B .
Dividend declared on 29 Dec 2020
A dividend of ₩1.00K per share was announced, adjusted to ₩961.17. The dividend was paid on 16 Apr 2021.
Earnings released on 16 Nov 2020
EPS came in at ₩492.00 falling short of the estimated ₩496.45 by -0.90%, while revenue for the quarter reached ₩145.61B .
170900.KS Stock Performance
Access detailed 170900.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.